Futura Medical Regulatory News (FUM)

For immediate release

11 November 2014

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")

Period of return:

From: 28 April 2014To: 10 November 2014

Number and class of securities not issued under the scheme(s)

USOS: 1,786,435 ordinary shares of 0.2p

EMI: 1,828,306 ordinary shares of 0.2p

Total: 3,614,741

Number of securities issued under the scheme(s) during the period

USOS: Nil

EMI: Nil

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS: 1,786,435

EMI: 1,828,306Total: 3,614,741

Number and class of securities originally admitted and the date of admission

USOS: 814,424 on 25 May 2011 and 1,193,959 on 8 October 2013Total: 2,008,383 Total

EMI: 1,520,576 on 25 May 2011 and 1,476,041 on 8 October 2013Total: 2,996,617 Total

Total: 5,005,000

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com

Nominated Adviser:

N+1 Singer

Aubrey Powell

Tel:+44 (0)20 7496 3000

For media enquiries please contact:

Buchanan

Mark Court / Sophie Cowles

Tel: +44 (0)20 7466 5000